Your browser doesn't support javascript.
Poor outcome of patients with COVID-19 after CAR T-cell therapy for B-cell malignancies: results of a multicenter study on behalf of the European Society for Blood and Marrow Transplantation (EBMT) Infectious Diseases Working Party and the European Hematology Association (EHA) Lymphoma Group.
Spanjaart, Anne Mea; Ljungman, Per; de La Camara, Rafael; Tridello, Gloria; Ortiz-Maldonado, Valentín; Urbano-Ispizua, Alvaro; Barba, Pere; Kwon, Mi; Caballero, Dolores; Sesques, Pierre; Bachy, Emmanuel; Di Blasi, Roberta; Thieblemont, Catherine; Calkoen, Friso; Mutsaers, Pim; Maertens, Johan; Giannoni, Livia; Nicholson, Emma; Collin, Matthew; Vaz, Carlos Pinho; Metafuni, Elisabetta; Martinez-Lopez, Joaquin; Dignan, Fiona L; Ribera, Josep-Maria; Nagler, Arnon; Folber, Frantisek; Sanderson, Robin; Bloor, Adrian; Ciceri, Fabio; Knelange, Nina; Ayuk, Francis; Kroger, Nicolaus; Kersten, Marie José; Mielke, Stephan.
  • Spanjaart AM; Department of Hematology, Amsterdam University Medical Centers, Cancer Center Amsterdam and LYMMCARE, Amsterdam, The Netherlands.
  • Ljungman P; Department of Cellular Therapy and Allogeneic Stem Cell Transplantation (CAST), Karolinska University Hospital Huddinge and Karolinska Comprehensive Cancer Center, Stockholm, Sweden.
  • de La Camara R; Department of Medicine Huddinge, Karolinska Institutet, Stockholm, Sweden.
  • Tridello G; Department of Hematology, Hospital Universitario de La Princesa, Madrid, Spain.
  • Ortiz-Maldonado V; Pediatric Hematology Oncology, Azienda Ospedaliera Universitaria Integrata, Verona, Italy.
  • Urbano-Ispizua A; Department of Hematology, Hospital Clínic, Barcelona, Spain.
  • Barba P; Department of Hematology, Hospital Clínic, Barcelona, Spain.
  • Kwon M; Department of Hematology, Vall d'Hebron University Hospital, Vall d'Hebron, Barcelona, Spain.
  • Caballero D; Department of Hematology, Institute of Health Research Gregorio Marañon, Hospital G. Universitario Gregorio Marañon, Madrid, Spain.
  • Sesques P; Department of Hematology, Hospital Universitario de Salamanca, IBSAL, Salamanca, Spain.
  • Bachy E; Department of Hematology, Hospices Civils de Lyon, Lyon Sud Hospital, Lyon, Pierre-Bénite, France.
  • Di Blasi R; Department of Hematology, Hospices Civils de Lyon, Lyon Sud Hospital, Lyon, Pierre-Bénite, France.
  • Thieblemont C; Department of Hematology, Assistance Publique Hôpitaux de Paris-Hopital Saint-Louis, Paris, France.
  • Calkoen F; Department of Hematology, Assistance Publique Hôpitaux de Paris-Hopital Saint-Louis, Paris, France.
  • Mutsaers P; Department of Stem cell Transplantation,Princess Maxima Centre for Paediatric Oncology, University Medical Centre Utrecht, Utrecht, The Netherlands.
  • Maertens J; Department of Hematology, Erasmus MC Cancer Center, Rotterdam, The Netherlands.
  • Giannoni L; Deptartment of Hematology, University Hospital Gasthuisberg, Leuven, Belgium.
  • Nicholson E; Ematologia e Centro Trapianti, IRCCS Ospedale Policlinico San Martino, Genova, Italy.
  • Collin M; Department of Haematology, The Royal Marsden Hospital, London, UK.
  • Vaz CP; Adult HSCT Unit, Northern Centre for Bone Marrow Transplantation, Newcastle Tyne, UK.
  • Metafuni E; BMT Unit, Inst. Português de Oncologia do Porto, Porto, Portugal.
  • Martinez-Lopez J; Dipartimento di Diagnostica per Immagini, Radioterapia Oncologica ed Ematologia, Fondazione Policlinico Universitario A. Gemelli IRCCS, Roma, Italy.
  • Dignan FL; Department of Hematology, Hospital Univ. 12 de Octubre, CNIO, Complutense University, Madrid, Spain.
  • Ribera JM; Clinical Haematology Department, Manchester Royal Infirmary, Manchester, UK.
  • Nagler A; Clinical Hematology Department, Catalan Institute of Oncology, Hospital Germans Trias i Pujol, Josep Carreras Research Institute, Barcelona, Spain.
  • Folber F; Chaim Sheba Medical Center, Tel Aviv University, Tel HaShomer, Tel Aviv-Yafo, Israel.
  • Sanderson R; Department of Internal Medicine, Hematology and Oncology, University Hospital Brno, Brno, Czechia.
  • Bloor A; Department of Haematological Medicine, Kings College Hospital, London, UK.
  • Ciceri F; Adult Leukaemia and Bone Marrow Transplant Unit, Christie NHS Trust Hospital, University of Manchester, Manchester, UK.
  • Knelange N; Hematology and BMT Unit, IRCCS San Raffaele Scientific Institute, Milan, Italy.
  • Ayuk F; Dept. of Medical Statistics & Bioinformatics, EBMT Data Office, Leiden, The Netherlands.
  • Kroger N; Department of Stem Cell Transplantation, University Hospital Eppendorf, Hamburg, Germany.
  • Kersten MJ; Department of Stem Cell Transplantation, University Hospital Eppendorf, Hamburg, Germany.
  • Mielke S; Department of Hematology, Amsterdam University Medical Centers, Cancer Center Amsterdam and LYMMCARE, Amsterdam, The Netherlands.
Leukemia ; 35(12): 3585-3588, 2021 12.
Article in English | MEDLINE | ID: covidwho-1506854
Subject(s)
Fulltext
Print
XML
PubMed Links
Search on Google

Full text: Available Collection: International databases Database: MEDLINE Main subject: Leukemia, B-Cell / Lymphoma, B-Cell / COVID-19 Type of study: Experimental Studies / Prognostic study Topics: Long Covid Limits: Humans Country/Region as subject: Europa Language: English Journal: Leukemia Journal subject: Hematology / Neoplasms Year: 2021 Document Type: Article Affiliation country: S41375-021-01466-0

Similar

MEDLINE
LILACS
LIS
Fulltext
Print
XML
PubMed Links
Search on Google

Full text: Available Collection: International databases Database: MEDLINE Main subject: Leukemia, B-Cell / Lymphoma, B-Cell / COVID-19 Type of study: Experimental Studies / Prognostic study Topics: Long Covid Limits: Humans Country/Region as subject: Europa Language: English Journal: Leukemia Journal subject: Hematology / Neoplasms Year: 2021 Document Type: Article Affiliation country: S41375-021-01466-0